Early-Phase Clinical Scientist — Lead Groundbreaking Trials

Parexel; United States; Remote; USD 120,000 - 170,000; Full time

Job summary

Parexel in the United States is seeking an Early Clinical Scientist (ECS) to lead or support early phase clinical studies with accountability for the clinical and scientific execution of the protocol. The role collaborates with the Clinical Director and cross-functional teams to ensure robust data, patient safety, and regulatory compliance.

This position requires experience in managing CROs for Phase 1 trials, strong scientific writing, and proficiency with trial management tools, enabling

Qualifications

• Degree in Life Sciences or related field.
• Experience in managing CROs for Phase 1 trials.
• Experience with CTMS/TMF systems.
• Proven ability to author protocol concepts and conduct cross-functional collaboration.

Responsibilities

• Coordinate design, planning and execution of early phase trials with Clinical Director and teams.
• Oversee trials within programs/therapeutic areas ensuring data validity and regulatory compliance.
• Co-author clinical sections of protocols and reports; develop study documents.
• Review budgets and vendor invoices where applicable.

Skills

MS Office Suite

Team collaboration

Leadership

Written & verbal communication

English proficiency

Project management

Cross-functional coordination

Quick scientific learning

Education

Life Sciences degree

Bachelor's degree + 7+ years experience

Master's degree + 5+ years experience

PhD or doctorate + 1+ year experience

Tools

Clinical Trial Management Systems

Trial Master File systems

Job description

Parexel in the United States is seeking an Early Clinical Scientist (ECS) to lead or support early phase clinical studies with accountability for the clinical and scientific execution of the protocol. The role collaborates with the Clinical Director and cross-functional teams to ensure robust data, patient safety, and regulatory compliance.

This position requires experience in managing CROs for Phase 1 trials, strong scientific writing, and proficiency with trial management tools, enabling